Stabilised Tat antigen and the use thereof for anti-HIV vaccination

The invention relates to a vaccine composition comprising at least one type of anti-HIV vaccine composition containing at least one type of stabilised Tat antigen and to the use thereof for preventing and/or treating a human HIV infection.

Saved in:
Bibliographic Details
Main Authors DREVET, PASCAL, LECOQ, ALAIN, MENEZ, ANDRE, MOINE, GERVAISE, LAJEUNESSE, EVELYNE, LEONETTI, MICHEL, THAI, ROBERT
Format Patent
LanguageEnglish
Published 25.08.2011
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a vaccine composition comprising at least one type of anti-HIV vaccine composition containing at least one type of stabilised Tat antigen and to the use thereof for preventing and/or treating a human HIV infection.
Bibliography:Application Number: AU20050230425